Pediatric Cancer | CHOP Research Institute
 

Pediatric Cancer

Holveck Family Gift Expedites Research for Rare Cancers

Published on
Nov 16, 2023
in Cornerstone Blog
Through the Connor Initiative, CHOP researchers are working to unlock novel therapies that will change the standard of care for osteosarcoma.
The Connor Initiative, a multimillion dollar gift from the Holveck Family, will support precision therapeutics for osteosarcoma and rare cancers.

Mitochondria and Cancer Connections (MC²) Research Program

Mitochondria and Cancer Connections (MC²) Research Program

The Mitochondria and Cancer Connections (MC2) Research program leverages knowledge from existing centers to establish a novel, cutting-edge research initiative and enable the development of mechanistic understanding and novel therapeutic opportunities at the intersection of mitochondrial disease and pediatric cancer.

In The News: Food Allergies, Telemedicine, Parkway Run, Fungal Disease, Sickle Cell Documentary

Published on
Sep 30, 2022
in Cornerstone Blog
In the News
Learn about novel findings and new grants from Children’s Hospital of Philadelphia researchers.

ON-TRK

ON-TRK

The goal of this observational study is to describe the safety and effectiveness of larotrectinib in patients with locally advanced or metastatic TRK fusion cancer for whom a decision to treat with larotrectinib has been made before enrollment.

CHOP Researchers Join Global Team to Take On Solid Cancers

Published on
Jun 29, 2022
in Cornerstone Blog
CHOP Researchers Join Global Team to Take On Solid Cancers
CHOP scientists are part of a Cancer Grand Challenges team receiving $25 million to tackle solid tumors.
Evan Weber, PhD
Evan W. Weber

Dr. Weber is developing approaches to enhance CAR-T cell therapies for pediatric cancer by reprogramming T cells with improved durability and exhaustion resistance. His work will uncover molecular mechanisms that promote CAR-T cell exhaustion and identify new targets for therapeutic intervention.

E-mail:
weberew [at] chop.edu

CHOP to Host ‘Personalizing Pediatric Cancer Care’ Summit

Published on
Jan 28, 2022
in Cornerstone Blog
CHOP to Host ‘Personalizing Pediatric Cancer Care’ Summit
World-class experts will gather at CHOP summit to present on scientific advances in pediatric cancer care in the diagnostics and therapeutic space.

Chemotherapy-induced Nausea and Vomiting Control

The overall goal of this study is to find the best strategies used by parents and patients for managing these symptoms when receiving maintenance therapy.

MC² Program Energizes Research Between Mitochondrial Disease and Pediatric Cancer

Published on
Sep 22, 2021
in Cornerstone Blog
MC² Program Energizes Research Between Mitochondrial Disease and Pediatric Cancer
Marni Falk, MD, and Adam Resnick, PhD, to lead the Mitochondria and Cancer Connections (MC²) Research Program, a new CHOP research initiative.

Bosse Laboratory

Bosse Lab

The Bosse Lab focuses on the development of new immune-based therapies for neuroblastoma, an embryonal malignancy of the developing nervous system.